Renin-Inhibitors Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Renin-Inhibitors Market was valued at 70.79 Million USD in 2020 and will grow with a CAGR of 6% during the forecast period 2022 to 2028.

Renin inhibitors are medicines that reduce the formation of geotensin II, which lowers blood pressure by inhibiting the activity of renin, which is responsible for the hydrolysis of geotensinogen to geotensin I. Renin is a proteolytic enzyme secreted in response to sympathetic activation, decreased sodium transport, and hypotension from the kidney to the distal tubule. It converts angiotensinogen to angiotensin I later by angiotensin converting enzyme. Angiotensin II is a potent vasoconstrictor that raises blood pressure. Renin inhibitors block the activity of renin and induce vasodilation, and are called a group of drugs mainly used for the treatment of essential hypertension. First- and second-generation drugs faced problems such as low bioavailability and lack of efficacy, but third-generation drugs allowed oral bioavailability and were robust enough for clinical use. Aliskiren (INN) is the first in a class of drugs called direct renin inhibitors. The currently approved indication is essential (primary) hypertension.

Market Segments

By Product Type

• 150mg/Tablet
• 300mg/Tablet

By Application

• Below 45
• 46-55
• 55-65
• Above 66

Key Players

• Johnson & Johnson
• Pfizer
• Bio-Rad Laboratories Inc.
• Sanofi
• Lupin
• Merck & Co.
• Astra Zeneca
• Daiichi Sankyo
• Novartis

Scope of the Report

The research study analyzes the global Renin-Inhibitors industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Renin-Inhibitors Market Report

1. What was the Renin-Inhibitors Market size in 2020 and 2021; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Renin-Inhibitors Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Renin-Inhibitors Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.